-
公开(公告)号:EP2516445B1
公开(公告)日:2015-03-11
申请号:EP10799203.4
申请日:2010-12-17
申请人: Cephalon, Inc.
发明人: BACON, Edward R. , BAILEY, Thomas R. , DUNN, Derek D. , HOSTETLER, Greg A. , MCHUGH, Robert J. , MORTON, George C. , ROSSE, Gerard C. , SALVINO, Joseph M. , SUNDAR, Babu G. , TRIPATHY, Rabindranath
IPC分类号: C07D491/048 , C07D491/20 , C07D513/04 , C07D491/153 , A61K31/4355 , A61P25/06 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P25/32 , A61P25/36
CPC分类号: C07D491/153 , C07D491/048 , C07D491/20 , C07D513/04
-
公开(公告)号:EP2516445A2
公开(公告)日:2012-10-31
申请号:EP10799203.4
申请日:2010-12-17
申请人: Cephalon, Inc.
发明人: BACON, Edward R. , BAILEY, Thomas R. , DUNN, Derek D. , HOSTETLER, Greg A. , MCHUGH, Robert J. , MORTON, George C. , ROSSE, Gerard C. , SALVINO, Joseph M. , SUNDAR, Babu G. , TRIPATHY, Rabindranath
IPC分类号: C07D491/048 , C07D491/20 , C07D513/04 , C07D491/153 , A61K31/4355 , A61P25/06 , A61P25/08 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/24 , A61P25/28 , A61P25/30 , A61P25/32 , A61P25/36
CPC分类号: C07D491/153 , C07D491/048 , C07D491/20 , C07D513/04
摘要: This application relates to tricyclic compounds of Formula (I), including all stereoisomers, mixtures of stereoisomers, and salts thereof. This application also relates to compositions comprising compounds of Formula (I) and uses therefore.
-
3.SUBSTITUTED HEXAHYDROCHROMENO[3,4-B]PYRROLES WITH AFFINITY FOR THE SEROTONIN RECEPTOR (5-HT) FAMILY 有权
标题翻译: 取代HEXAHYDROCHROMENO [3,4-B]具有血清素受体的亲和力吡咯(5-HT)家族公开(公告)号:EP2516446B1
公开(公告)日:2014-08-13
申请号:EP10801042.2
申请日:2010-12-17
申请人: Cephalon, Inc.
IPC分类号: C07D491/052 , A61K31/4439 , A61P25/00 , A61P1/00 , A61P3/00
CPC分类号: C07D491/052
-
4.SUBSTITUTED HEXAHYDROCHROMENO[3,4-B]PYRROLES WITH AFFINITY FOR THE SEROTONIN RECEPTOR (5-HT) FAMILY 有权
标题翻译: 取代HEXAHYDROCHROMENO [3,4-B]具有血清素受体的亲和力吡咯(5-HT)家族公开(公告)号:EP2516446A2
公开(公告)日:2012-10-31
申请号:EP10801042.2
申请日:2010-12-17
申请人: Cephalon, Inc.
IPC分类号: C07D491/052 , A61K31/4439 , A61P25/00 , A61P1/00 , A61P3/00
CPC分类号: C07D491/052
摘要: This application relates to tricyclic compounds of Formula (I), including all stereoisomeric forms, all mixtures of stereoisomeric forms, and salts of these compounds. This application also relates to compositions comprising compounds of Formula (I), stereoisomeric forms, all mixtures of stereoisomeric forms, and salts thereof and uses therefor.
-
-
-